BridgeMD
Tests treatment safety and results for Generalized Anxiety Disorder
Official title RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
ClinicalTrials.gov ID: NCT07489651
What this study is testing
What is RE104 for Injection?
RE104 for Injection is an investigational medicine, given as an injection under the skin, being studied as a potential treatment for generalized anxiety disorder.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces anxiety symptoms in participants with Generalized Anxiety Disorder (GAD) as compared to placebo.
- Phase 2: a mid-size study of how well it works
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 74
You may be able to join if
- Has Generalized Anxiety Disorder as defined by DSM-5-TR
- If female is not pregnant or planning to become pregnant. If male is not planning to make a partner pregnant.
- Is willing and able to comply with the conditions and requirements of the study
You likely can't join if
- Has a significant risk of suicide
- Has an active or medical history of bipolar disorder, schizophrenia, schizoaffective disorder, psychotic disorder and/or borderline personality...
- Has other concurrent psychiatric disorders that is the primary disorder.
- Has other medically significant conditions rendering unsuitability for the study
- Has used or will need to use prohibited medications or therapies
- Has a known sensitivity or intolerance to study intervention or potential rescue medications
The study team makes the final eligibility decision.
Where it's taking place
- Gilbert, Arizona, United States
- Little Rock, Arkansas, United States
- Garden Grove, California, United States
- La Jolla, California, United States
- San Francisco, California, United States
- Santa Monica, California, United States
- Lauderhill, Florida, United States
- Tampa, Florida, United States
- Atlanta, Georgia, United States
- Decatur, Georgia, United States
- Chicago, Illinois, United States
- Novi, Michigan, United States
- Saint Charles, Missouri, United States
- Albuquerque, New Mexico, United States
- New York, New York, United States
- North Canton, Ohio, United States
- Portland, Oregon, United States
- Austin, Texas, United States
- Plano, Texas, United States
- Draper, Utah, United States
+ 1 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 74 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Gilbert, Arizona, United States; Little Rock, Arkansas, United States; Garden Grove, California, United States; La Jolla, California, United States; San Francisco, California, United States; Santa Monica, California, United States and 15 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.